Toshiba will continue offering Vital Images' Vitrea 2 software through subsidiaries and distributors in more than 50 countries under a renewed agreement announced Jan. 9. Toshiba has been offering the software as the 3D medical imaging product of choice
Toshiba will continue offering Vital Images' Vitrea 2 software through subsidiaries and distributors in more than 50 countries under a renewed agreement announced Jan. 9. Toshiba has been offering the software as the 3D medical imaging product of choice to customers purchasing its Aquilion multidetector CTs. The new agreement includes a minimum worldwide revenue commitment from Toshiba of more than $5 million and is effective through Sept. 30, 2003. It can be renewed with the mutual consent of Vital Images and Toshiba.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.